NIBR 0213

Product Name: NIBR 0213
CAS No.: 1233332-14-3
Chemical Name: NIBR 0213
Synonyms: NIBR 0213;NIBR-0213 >=98% (HPLC);NIBR-0213, 10 mM in DMSO;KYHUARFFBDLROH-MOPGFXCFSA-N;(3'-(((R)-1-(4-Chloro-3-methylphenyl)ethyl)amino)-3,5-dimethyl-[1,1'-biphenyl]-4-carbonyl)-L-alanine;(3'-(((R)-1-(4-Chloro-3-methylphenyl)ethyl)amino)-3,5-dimethyl-[1,1'-biphenyl]-4-carbonyl)-L-alanine;N-[[3'-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]-L-alanine;(2S)-2-[[4-[3-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]phenyl]-2,6-dimethylbenzoyl]amino]propanoic acid;L-Alanine, N-[[3'-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]-;Lysophospholipid Receptor,S1P1,Inhibitor,LPL Receptor,NIBR0213,encephalomyelitis,autoimmune,NIBR-0213,inhibit
CBNumber: CB42668440
Molecular Formula: C27H29ClN2O3
Formula Weight: 464.98
MOL File: 1233332-14-3.mol

More

Less

NIBR 0213 Property

storage temp.: Store at -20°C
solubility: DMF: 25 mg/ml; DMSO: 25 mg/ml; Ethanol: 25 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.15 mg/ml
form: A crystalline solid
color: Off-white to light yellow
InChIKey: KYHUARFFBDLROH-MOPGFXCFSA-N
SMILES: C(O)(=O)[C@H](C)NC(C1=C(C)C=C(C2=CC=CC(N[C@@H](C3=CC=C(Cl)C(C)=C3)C)=C2)C=C1C)=O

More

Less

Safety

WGK Germany: WGK 3
Storage Class: 11 - Combustible Solids

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: SML2099
Product name: NIBR-0213
Purity: ≥98% (HPLC)
Packaging: 5 mg
Price: $84.7
Updated: 2025/07/31

Sigma-Aldrich

Product number: SML2099
Product name: NIBR-0213
Purity: ≥98% (HPLC)
Packaging: 25 mg
Price: $517.75
Updated: 2025/07/31

Cayman Chemical

Product number: 21513
Product name: NIBR0213
Purity: ≥98%
Packaging: 1mg
Price: $36
Updated: 2024/03/01

Cayman Chemical

Product number: 21513
Product name: NIBR0213
Purity: ≥98%
Packaging: 5mg
Price: $109
Updated: 2024/03/01

Cayman Chemical

Product number: 21513
Product name: NIBR0213
Purity: ≥98%
Packaging: 10mg
Price: $198
Updated: 2024/03/01

More

Less

NIBR 0213 Chemical Properties,Usage,Production

Uses

NIBR 0213 is a potent and selective inhibitor of sphingosine 1-phosphate receptor-1 (S1P1), a G protein-coupled receptor that has been highlighted as a promising therapeutic target in autoimmunity disorders.

Biological Activity

NIBR-0213 is an orally active, potent and S1P1-selective sphingosine 1-phosphate (S1P) receptor antagonist th at blocks S1P1-selective ligand AUY954-induced Ca2+ mobilization (IC50 = 2.5 nM using human S1P1-transfected HeLa cells; IC50 >10 μM with human S1P2, S1P3, or S1P4 transfectants) and S1P-induced GTPγS recruitment (IC50 = 2.0/2.3/8.5 nM using membrane from human/murine/r at S1P1-transfected CHO cells; IC50 >10 μM with membrane from human S1P5 transfectant). NIBR-0213 induces long-lasting peripheral blood lymphocyte reduction in rats (EDmax = 1 mg/kg, ED50 = 0.2 mg/kg; p.o.) and exhibits therapeutic efficacy (30 mg/kg p.o; BID) in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), with no adverse effects to the animals.

in vivo

NIBR-0213 (given orally at 30 mg/kg to rats) reduces the peripheral blood lymphocyte (PBL) counts by 75%-85% within 14 hr and maintained this effect up to 24 hr posttreatment^[1].
NIBR-0213 (30 mg/kg and 60 mg/kg) is efficacious when given therapeutically in a mouse experimental autoimmune encephalomyelitis (EAE) model^[1].
The PK properties of NIBR-0213 shows a moderate clearance (26 mL/min/kg) and a high oral bioavailability (69%), leading to significant exposure after oral dosing^[1].

Animal Model:	Lewis or Wistar rats (220-250 g, males)^[1]
Dosage:	30mg/kg
Administration:	Orally
Result:	Reduced the PBL counts by 75%-85% within 14hr and maintained this effect up to 24hr posttreatment.

Animal Model:	C57BL/6 mice bearing EAE model^[1]
Dosage:	30mg/kg and 60mg/kg
Administration:	30mg/kg twice per day (BID) for 3days and then increased to 60mg/kg BID until the remainder of the experiment. In total, the treatment lasted 26days
Result:	Resulted in a gradual reduction in disease-scores, with a divergence from vehicle controls that became significant after 5days.

NIBR 0213 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

NIBR 0213 Suppliers

China 39 United States 4 Global 43

Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd

Tel: 024-024-024-88590548 18341751992
Email: 757984502@qq.com
Country: China
ProdList: 962
Advantage: 58

Shanghai XingMo Biotechnology Co., Ltd.

Tel: +86 13524779951; 13524779951
Fax: QQ: 2075692521
Email: 2075692521@qq.com
Country: China
ProdList: 300
Advantage: 55

Shanghai Lollane Biological Technology Co.,Ltd.

Tel: 021-52996696，15000506266 15000506266
Fax: +86-21-52996696
Country: China
ProdList: 4800
Advantage: 55

Shanghai EFE Biological Technology Co., Ltd.

Tel: 021-65675885 18964387627
Fax: 021-65675885
Email: info@efebio.com
Country: China
ProdList: 9803
Advantage: 58

Shanghai YuanYe Biotechnology Co., Ltd.

Tel: 021-61312847; 18021002903
Fax: QQ:3008007432
Email: 3008007409@qq.com
Country: China
ProdList: 71826
Advantage: 60

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8000
Advantage: 62

Shanghai Rechem science Co., Ltd.

Tel: 021-31433387 15618786686
Fax: QQ:1369748377
Email: sales@rechemscience.com
Country: China
ProdList: 2961
Advantage: 58

TargetMol Chemicals Inc.

Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 32470
Advantage: 58

Career Henan Chemica Co

Tel: +86-0371-86658258 +8613203830695
Fax: 0371-86658258
Email: laboratory@coreychem.com
Country: China
ProdList: 30229
Advantage: 58

Changzhou Chenhong Biotechnology Co., Ltd.

Tel: +86-0519-85788828 +86-13775037613
Email: sales@chemrenpharm.com
Country: China
ProdList: 4023
Advantage: 58

1233332-14-3, NIBR 0213Related Search:

NIBR 0213

KYHUARFFBDLROH-MOPGFXCFSA-N

L-Alanine, N-[[3'-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]-

NIBR-0213 >=98% (HPLC)

Lysophospholipid Receptor,S1P1,Inhibitor,LPL Receptor,NIBR0213,encephalomyelitis,autoimmune,NIBR-0213,inhibit

N-[[3'-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]-L-alanine

(3'-(((R)-1-(4-Chloro-3-methylphenyl)ethyl)amino)-3,5-dimethyl-[1,1'-biphenyl]-4-carbonyl)-L-alanine

(2S)-2-[(3'-{[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino}-3,5-dimethyl-[1,1'-biphenyl]-4-yl)formamido]propanoic acid

NIBR-0213, 10 mM in DMSO

(2S)-2-[[4-[3-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]phenyl]-2,6-dimethylbenzoyl]amino]propanoic acid

(3'-(((R)-1-(4-Chloro-3-methylphenyl)ethyl)amino)-3,5-dimethyl-[1,1'-biphenyl]-4-carbonyl)-L-alanine

1233332-14-3